The health department says ViiV Healthcare’s newly announced non-profit price between R540 and R570 per shot for a two-monthly anti-HIV jab is more than four times what it can afford to pay.
Towards the end of the year, donated batches of the anti-HIV jab CAB-LA will arrive in South Africa. The two-monthly jab will be used in implementation trials and virtually wipes out one’s chances of contracting HIV through sex.
Bhekisisa spoke to three women who’ve become HIV prevention advocates in their communities. They also tell us how the CAB-LA injection has changed their lives
South Africa’s medicine regulator, Sahpra, has registered CAB-LA, a new anti-HIV jab. But for how much will drugmaker ViiV Healthcare sell it to the government?